Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Curaleaf Holdings ( (TSE:CURA) ) is now available.
Curaleaf Holdings, Inc. reported on May 6, 2026, that its independent auditor PKF O’Connor Davies, LLP will resign effective that date, and BDO USA, P.C. will be appointed as successor auditor to serve until the next annual shareholders’ meeting. The board-approved change follows an unqualified audit history, with Curaleaf stating that the former auditor issued no modified opinions in the past two fiscal years and that no reportable events occurred, suggesting the transition is a routine governance step rather than a response to accounting concerns.
The company filed the change of auditor notice under Canadian continuous disclosure rules, reflecting its obligations as a foreign private issuer listed in U.S. markets. The notice, signed by Chief Financial Officer Ed Kremer and Chief Legal Officer Peter Clateman, underscores Curaleaf’s effort to formally document the auditor transition for investors and regulators while signaling continuity in financial reporting oversight.
The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$5.00 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on CURA Stock
According to Spark, TipRanks’ AI Analyst, CURA is a Neutral.
Overall score reflects strong technical momentum and attractive P/E valuation, balanced against a still-developing fundamental profile (ongoing net losses and leverage). The earnings call added support via improving results, constructive guidance, and refinancing progress, partially offset by margin compression and working-capital/cash-flow pressures.
To see Spark’s full report on CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings, Inc. is a cannabis company based in Vancouver, British Columbia, operating as a foreign private issuer in the U.S. securities markets. The firm is subject to Canadian continuous disclosure rules and files its reports with the U.S. Securities and Exchange Commission under the Form 40-F framework.
YTD Price Performance: 56.01%
Average Trading Volume: 800,454
Technical Sentiment Signal: Buy
Current Market Cap: C$4.12B
Learn more about CURA stock on TipRanks’ Stock Analysis page.